OncoVerity
OncoVerity leverages a unique computational biology platform to advance oncology therapeutics, starting with cusatuzumab, a novel, first-in-class high-affinity, anti-CD70 monoclonal antibody.
Address
AuroraCO
United States
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}